Promethazine-Codeine Should NOT Be Used in Patients Aged 12-18 Years
Promethazine-codeine is contraindicated in all patients under 18 years of age for post-surgical pain, and should be used with extreme caution (if at all) in adolescents aged 12-18 years for other indications due to serious respiratory depression risks, particularly in those with obesity or conditions like obstructive sleep apnea. 1
FDA and Guideline Restrictions
The 2021 JAMA Surgery expert panel explicitly endorses FDA guidelines that severely restrict codeine use in pediatrics 1:
- Absolutely contraindicated in children under 12 years for any indication
- Absolutely contraindicated in all patients under 18 years following tonsillectomy/adenoidectomy
- Strong warning against use in adolescents 12-18 years who are obese or have conditions increasing respiratory risk (obstructive sleep apnea, severe lung disease)
These restrictions stem from documented cases of respiratory depression and death in rapid CYP2D6 metabolizers who convert codeine to excessive morphine levels 2.
If Use Is Considered Despite Warnings (Ages 12-18, Non-Surgical)
The FDA label provides dosing only for promethazine alone, not the combination product 3:
For nausea/vomiting in children:
- 0.5 mg per pound body weight of promethazine
- Adjust for age, weight, and condition severity
- May repeat 12.5-25 mg doses every 4-6 hours as needed
However, this does NOT include codeine dosing for this age group, as the combination is essentially contraindicated.
Critical Safety Considerations
Common pitfalls to avoid:
- Do not assume "appropriate weight-based dosing" is safe—fatal respiratory depression has occurred even with correct dosing 2
- Genetic polymorphisms in CYP2D6 cannot be predicted clinically without testing
- Risk is highest in the home setting post-discharge where monitoring is absent 2
Recommended Alternatives
Rather than using promethazine-codeine, consider 1:
- Acetaminophen as first-line
- Ketorolac for additional analgesia
- Dexamethasone (reduces opioid requirements and nausea)
- Regional anesthesia techniques when applicable
- If opioids are absolutely necessary, use alternatives to codeine (though all carry respiratory risks)
The evidence is unequivocal: the mortality risk from respiratory depression outweighs any analgesic benefit of promethazine-codeine in this age group.